A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissues

Noam Shomron, Nobuko Hamasaki-Katagiri, Ryan Hunt, Klilah Hershko, Elie Pommier, S. Geetha, Adam Blaisdell, Andrew Marple, Isabella Roma, Jordan Newell, Courtni Allen, Scott Friedman, Chava Kimchi-Sarfaty

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Although ADAMTS13, the von Willebrand factor (VWF)-cleaving protease, is expressed in a range of tissues, the physiological significance of tissue-specific ADAMTS13 alternative splicing isoforms have yet to be clarified. Screening a panel of human tissues and cell lines revealed a spliced ADAMTS13 transcript in hepatic stellate cells and a hepatoma cell line that retains the 25th intron. A nonsense codon within the intron truncates the protease, which gains 64 novel amino acids in lieu of both CUB domains. This isoform, while retaining VWF-cleaving capability, accumulates intracellularly and its biological inaccessibility may prevent its participation in regulating haemostasis and other physiologic functions.

Original languageEnglish
Pages (from-to)531-535
Number of pages5
JournalThrombosis and Haemostasis
Volume104
Issue number3
DOIs
StatePublished - Sep 2010

Keywords

  • ADAMTS13
  • Alternative splicing
  • Cub domain
  • Intron retention
  • TTP

Fingerprint

Dive into the research topics of 'A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissues'. Together they form a unique fingerprint.

Cite this